En 2008, la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) publicó las
primeras normativas del mundo sobre el diagnóstico y tratamiento de las bronquiectasias. Tras …

Objectives Despite the clinical relevance of exacerbations in bronchiectasis (BE), little is
known about the microbiology and outcomes of pneumonic (CAP) vs. non-pneumonic (NOCAP) …

… Rosa Maria Girón Moreno ha participado en reuniones de formación patrocinadas por
Gilead, … David de la Rosa ha participado en reuniones de formación patrocinadas por Praxis, …

Introducción Las bronquiectasias son la consecuencia final de múltiples patologías. Establecer
la etiología tiene implicaciones clínicas y pronósticas. El objetivo fue evaluar la etiología …

Objetivo Evaluar la prevalencia de micobacterias ambientales (MA) en pacientes con fibrosis
quística (FQ). Pacientes y métodos Se ha realizado un estudio prospectivo de 2 años de …

Background Patients with coronavirus disaese 2019 (COVID-19) can develop a cytokine
release syndrome that eventually leads to acute respiratory distress syndrome requiring …

… Rosa Maria Girón Moreno has participated in training sessions sponsored by Gilead, Teva
and … David de la Rosa has participated in training sessions sponsored by Praxis, Zambon and …

Bronchiectasis is a multidimensional disease and, therefore, its severity or prognosis cannot
be adequately quantified by analysing one single variable. The objective of the present …

Introduction Bronchiectasis is caused by many diseases. Establishing its etiology is important
for clinical and prognostic reasons. The aim of this study was to evaluate the etiology of …

… Rosa Maria Girón Moreno has participated in training sessions sponsored by Gilead, Teva
and … David de la Rosa has participated in training sessions sponsored by Praxis, Zambon and …